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& Abstract: Sleep problems are common in people with
low back pain (LBP); however, the mechanisms of how sleep
influences pain are complex. To date there is a lack of
prospective research on the timing and development of sleep
problems in those who have LBP; such information would be
useful to identify individuals at risk for poor outcomes. Our
aims are to investigate the predictive role of sleep problems
on self-report recovery and pain intensity using logistic
regression reporting odds ratios (ORs). An observational
cohort of 761 chronic LBP patients recruited from a pain
management clinic participated, and they completed data at
baseline and at 6-month follow-up (n = 682). Results show
increased odds for reported nonrecovery (OR 1.52) and pain
intensity (OR 2.69) among those who reported sleep prob-
lems at baseline. Further analysis on the experience of sleep
problems through time showed that those with developing
sleep problems (ie, no sleep problems at baseline but
reported sleep problems at follow-up) were at increased
odds for reporting nonrecovery (OR 2.17) and pain intensity
(OR 2.95), as were those who reported sleep problems at both
baseline and follow-up, for recovery (OR 2.88) and pain
intensity (OR 3.45). Those with resolving sleep problems (ie,
sleep problems present at baseline but not at follow-up) were
at decreased odds for nonrecovery (OR 0.50) and pain
intensity (0.49). Presenting, persistent, and developing sleep
problems have a significant impact on recovery for those with
LBP. Clinicians may wish to consider treatment options that
can address sleep problems. &
Key Words: low back pain, sleep, pain, recovery, prospec-
tive, cohort
INTRODUCTION
Low back pain (LBP) is a common condition affecting
most people at some point in their lives. A recent review
of 165 studies from 54 countries reported a point
prevalence rate of 18%, a 1-year prevalence rate of
38%, and a lifetime prevalence range of 40% to 80%.1
Recurrence of LBP is also common; a review of cohort
studies reported an estimated 70% recurrence rate over
5 years for those with LBP.2 This has led LBP to have a
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significant global impact in terms of disability to the
individual,3,4 as well as a significant financial impact—
LBP patients have higher direct and indirect costs
compared to other patient groups.5
Recently there has been a growth of research atten-
tion on the role of sleep, particularly sleep problems, and
on the effect this may have on outcomes for those with
LBP. Sleep problems associated with back pain are
common. A large epidemiological study reported that
over half of those who reported back pain also reported
sleep problems,6 and a review of 13 LBP studies showed
a prevalence rate of 58.9% for people ascribing sleep
problems to their back pain.7 The influence of pain on
sleep, and vice versa, is complex and most likely
reciprocal, with evidence of consistent associations
between LBP and sleep initiation, sleep disturbance,
sleep duration, sleep quality, electroencephalography
and polysomnography output, and poor daytime func-
tioning.8–10 Studies have shown associations between
increased poor sleep quality and increased pain inten-
sity,7 as well as experimental evidence of a lower pain
threshold due to sleep disturbance,11 and increased risk
for psychological morbidity (eg, depression) due to sleep
problems in those who report pain.12 Current thought
on the association between sleep disturbance and pain
suggests a key link is the relationship between sleep,
fatigue, and psychological morbidity (depression, anx-
iety), leading to a potential compounding effect on pain
perception, function, and recovery.7,8,10 Indeed, sleep
problems are a diagnostic feature of depression, and
therefore it is important to examine potential confound-
ing effects.12 There are also inflammatory processes
associated with the sleep cycle that may modulate
nociception.8 Evidence shows more sleep disturbances
are found within inflammatory populations (eg,
rheumatology and fibromyalgia populations),13,14 and
recent evidence on chronic LBP participants has shown
changes in proinflammatory markers (interleukin-6)
linked to sleep disturbance.15
However, to date prospective evidence is limited on
the relationship between LBP and sleep problems.
Little is known about the timing and sequences on the
development of sleep problems in those with back pain,
or the impact they have on recovery, something that is
reflected within the wider field of pain research.9 Such
information would be useful for clinicians to assist in
the identification of individuals who may require
additional interventions alongside usual pain manage-
ment (eg, sleep hygiene treatment). The primary aim of
the current study was to examine the prospective
predictive role of sleep problems associated with LBP
patient self-report recovery and pain intensity out-
comes. Secondary aims were to examine differences
over time between LBP patients who have no sleep
problems and those with sleep problems, those who
develop sleep problems over time, and those who have
a reduction of sleep problems over time. In line with
recent prospective evidence for the relationship
between sleep and pain,9 it is hypothesized that,
compared to those who do not report sleep problems,
those with developing sleep problems will be less likely
to report a favorable recovery, and those with persis-
tent sleep problems will have the worse outcomes
overall.
METHODS
This was a prospective study of patients with LBP,
carried out between February 2014 and December 2014.
Full ethical approval was granted by the Medical Ethics
Committee at Qazvin University of Medical Sciences,
Qazvin, Iran.
The cohort was inclusive of a convenience sample of
consecutive patients with LBP attending the Outpatient
Chronic Pain Clinic, Department of Neurosurgery,
Shahid Rajaee Hospital, Qazvin, Iran. Patients are
referred to this chronic pain clinic by their primary care
physicians, most often when pain persists beyond
normal healing time or if pain is recurrent or persistent.
Usual care at the chronic pain clinic involves patient
education (pain management), prescriptions (nons-
teroidal anti-inflammatory drugs), and physiotherapy
(exercise, spa therapy). Patients are normally assessed
for progress at 2-month intervals, and treatment usually
lasts for 1 year. Patients were eligible to participate in
the current study if they had a confirmed diagnosis of
chronic LBP (ie, persistent LBP with or without referred
leg pain for at least 3 months), were 18 years of age or
older, and were able to speak and read Persian. Patients
were excluded if they had any concurrent medical illness
(eg, cardiopulmonary, central nervous system, diabetes,
intellectual disorder, rheumatic diseases), serious spinal
pathology (eg, fracture, metastasis), and/or had received
spinal surgery. Patients scheduled to attend the outpa-
tient chronic pain clinic were approached over a 3-
month period (February 2014 to April 2014) and invited
to take part. As this was a convenience sample of
consecutive patients, the recruitment of patients to this
study was not aligned to the beginning of treatment for
each patient; variation existed on treatment type,
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treatment stage, pain level, and pain impact of the
participating patient population.
Patients were contacted by telephone and screened for
eligibility by one of the authors (M.Y.). Eligible patients
were invited to take part in the study at the same time as
their scheduled appointment. Informed consent was
obtained from patients at the time of their appointment,
and patients were asked to complete a questionnaire.
Subsequently patients were followed up at 6 months.
Measures
We used a single-item self-report global assessment
of change question for the patients’ perceived level of
recovery at 6-month follow-up.16,17 Such assessments of
global recovery have clinical relevance, have been found
to have high agreement with clinical assessment, and are
suitable for research due to their brevity and simplic-
ity.18 The question consists of 6 categories (completely
recovered, much better, better, no change, worse, much
worse), and participants were asked to select 1 category.
A cutoff was chosen for this measure on the basis of
clinical utility (eg, identification of a subgroup of
patients who may benefit from treatment due to no
change or worsening outcome over time). This variable
was collapsed to form 2 groups: a recovery group
(completely recovered, much better, and better) and a
nonrecovery group (no change, worse, much worse).
Pain intensity was measured using a visual analog
scale (VAS), and patients were asked to rate their pain
level when they filled out their baseline questionnaire
and at 6-month follow-up.6,19 For the logistic analysis
we based the cutoff of 0 or 1 (0 to 10 mm) as an
indication of patient recovery following previous
methodology carried out to identify patient-perceived
recovery from pain.20,21 Information was also collected
on the duration of LBP from patients at baseline.
Patients were asked to signify “How long is it since
you had a whole month without any pain?” We
categorized the pain duration question into 2 groups
for the analysis (6 months or less vs. 7 months or more)
following previous methodology.22,23
The Pittsburgh Sleep Quality Index (PSQI) was used
as a measure of overall sleep quality at baseline and at 6-
month follow-up. The PSQI measures quality and sleep
patterns using 7 domains: subjective sleep quality, sleep
latency, sleep duration, sleep efficiency, sleep distur-
bance, sleep medication, and daytime dysfunction over
the previous month. Scoring uses a 0- to 3-point Likert
scale, with a global score of 5 or greater indicating
clinically significant sleep problems; this global score
was used as the cutoff to identify those with sleep
problems in this study.24,25 The PSQI has been used
previously in numerous pain population studies26,27 and
has validation in Persian.28
Depressive and anxiety symptoms were assessed
using the Hospital Anxiety and Depression Scale
(HADS) at baseline. The HADS includes 2 scales
(depression and anxiety), and each scale comprises 7
items. All items are rated on a Likert-type scale ranging
from 0 to 3 points, with higher scores indicating higher
symptom levels, and with scores ranging from 0 to 21
for each scale.29 The HADS has been translated into
Iranian (Persian) and has been shown to be valid and
reliable in this setting.30
Patients were asked to provide information regarding
demographic characteristics at baseline: age, gender,
body mass index (BMI), and occupational status (work-
ing, sick leave, not working, retired).
Analysis
Descriptive statistics of the percentage proportions,
means, medians, and interquartile ranges were presented
for all the measures. Initially a prospective model was
tested using logistic regression producing odds ratios
(ORs) with 95% confidence intervals (95% CIs). Those
with sleep problems at baseline were tested against the
reference category of those with no sleep problems at
baseline, on both self-reported recovery status and pain
intensity outcome, at 6-month follow-up. A 2-stage
process was applied to each logistic regression model.
First, an unadjusted model was created to assess the
direct relationship between sleep problems and outcome
(self-report recovery, pain intensity), and then a multi-
variable model was created that included adjustment for
baseline depressive symptoms, baseline pain intensity
(within the patient self-report recovery model only),
baseline duration of pain, baseline anxiety symptoms,
age, gender, BMI, and occupational status. An adjusted
model may be used to demonstrate the relationship
between sleep problems and outcome while controlling
for potential confounding (eg, effect of depression on the
sleep-to-pain pathway), and the use of both unadjusted
and adjusted models allows for inspection of the
difference in change due to adjustment, which may
indicate potential mediation or suppression effects.
Further exploratory analysis using logistic regression
models was carried out to assess the full range of
experience of sleep problems at both baseline and
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follow-up (prospective and cross-sectional associations).
Four categories of participants were created based on
their sleep problem status at both time points (ie,
baseline and follow-up). The first category (no sleep
problems) was composed of participants who reported
no sleep problems at baseline or follow-up (used as the
reference category within the logistic regression). The
second category (developing sleep problems) was com-
posed of those participants who reported no sleep
problems at baseline, but did report sleep problems at
follow-up. The third category (persistent sleep prob-
lems) comprised those participants who reported sleep
problems at baseline and at follow-up. The final
category (resolving sleep problems) was composed of
those who reported sleep problems at baseline but did
not report sleep problems at follow-up. Data analysis
was conducted using IBM SPSS version 20.0 (IBM
Corp., Armonk, NY, U.S.A.).
RESULTS
In total, 807 participants were approached to take part
and 761 agreed at baseline, representing a 94% baseline
response rate. At 6-month follow-up, 682 participants
responded, representing an 89% response rate. Indepen-
dent t-tests or chi-square tests were performed to statis-
tically assess the difference in the patient’s age, gender,
BMI, depression, anxiety and pain intensity, occupation,
and sleep quality between those who responded at 6-
month follow-up and those who did not respond at 6-
month follow-up, and no differences were found.
Baseline characteristics showed a mean age of
41 years, with just over 55% of the cohort being male.
Just over 37% (n = 283) reported their last pain-free
monthwithin the previous6 months.At baseline, 48%of
the cohort indicated they had experienced sleep problems
in the previousmonth, and this rose to 67.6%at 6-month
follow-up, with only 4.5% of participants reporting
resolving sleep problems at follow-up. Self-reported
recovery at follow-up showed that 58.2% of the cohort
indicated they felt completely recovered, much better, or
better compared to how they felt at baseline. For pain
intensity, 38.3%% of the cohort reported VAS pain
intensity levels at 10 mmor below at 6-month follow-up.
Table 1 outlines the characteristics of the cohort.
Patient Self-Report Nonrecovery
Table 2 outlines the logistic regression analysis. Results
show that the presence of sleep problems at baseline
significantly increased the odds of poor recovery by
approximately 50% at 6-month follow-up (unadjusted
OR 1.52), and this result did not markedly change after
adjustment for confounds (adjusted OR 1.50). Explora-
tory analysis using the no sleep problem category (ie, no
reported sleep problems at baseline or follow-up) as the
reference category within logistic regression analysis
(see Table 2) showed that those with developing sleep
problems (ie, no sleep problems at baseline, reported
sleep problems at follow-up) were almost 3 times more
likely to report nonrecovery at 6 months (unadjusted
OR 2.93, 95% CI 1.53, 5.61), and those with persistent
sleep problems (ie, sleep problems reported both at
baseline and follow-up) were over 3 times more likely to
report a nonrecovery (unadjusted OR 3.24, 95% CI
1.63, 6.43), with those who had resolving sleep
Table 1. Cohort Characteristics
Characteristic n (%) Mean (SD)
Interquartile
Range
Baseline
Age 41.15 (12.24) 16
Gender (male) 414 (55.4)
PSQI sleep quality proportion
(sleep problems) and scale
score
365 (48.0) 10.5 (3.5) 5.0
VAS pain intensity 7.2 (2.31) 5.0
Depressive symptoms 7.8 (4.2) 5.0
Anxiety symptoms 11.8 (5.2) 8.0
BMI score 27.8 (6.3) 7.4
Last pain-free episode of back
pain over 7 months
478 (62.8)
Occupational status
Working 285 (37.5)
Sick leave 151 (19.8)
Not employed 220 (28.9)
Retired 105 (13.8)
6-month follow-up
PSQI sleep quality proportion
(sleep problems) and scale
score
461 (67.6) 9.32 (3.1) 5.0
Sleep problem categories
No sleep problems 190 (27.9)
Developing sleep
problems
165 (24.2)
Persistent sleep problems 296 (43.4)
Resolved sleep problems 31 (4.5)
Self-reported recovery
Completely recovered 143 (18.8)
Much better 91 (11.9)
Better 209 (27.5)
No change 58 (7.6)
Worse 114 (15.0)
Much worse 67 (8.8)
Missing 79 (10.4)
VAS pain intensity 5.1 (2.4) 5.0
Recovered
(VAS ≤ 10 mm)
261 (38.3)
Nonrecovery
(VAS > 10 mm)
421 (61.7)
PSQI, Pittsburgh Sleep Quality Index; VAS, visual analog scale; BMI, body mass index.
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problems (ie, sleep problems reported at baseline but
none reported at follow-up) having reduced odds for
nonrecovery (unadjusted OR 0.49, 95% CI 0.31, 0.78).
Within the fully adjusted model, results show that those
with developing sleep problems had over twice the odds
for nonrecovery (adjusted OR 2.17, 95%CI 1.04, 4.52),
those with persistent sleep problems had under 3 times
the odds for nonrecovery (adjusted OR 2.95, 95% CI
1.48, 5.88), and those with resolving sleep problems had
reduced odds for nonrecovery (adjusted OR 0.50, 95%
CI 0.31, 0.81) at 6 months.
Patient Pain Intensity
Results for pain intensity at follow-up as the outcome
(cutoff set at ≤ 10 mm on the VAS to indicate recovery)
show an increase in the odds for nonrecovery and higher
pain intensity for those with sleep problems at baseline,
with an approximate 2.5 times elevated risk (adjusted
OR 2.48, 95% CI 1.62, 3.70). Further exploratory
analysis showed that compared to those with no sleep
problems reported at baseline and follow-up, those with
developing sleep problems had an increased risk (almost
3 times) for nonrecovery in terms of pain intensity in
both unadjusted (OR 2.99, 95% CI 1.51, 5.92) and
adjusted analyses (OR 2.88, 95% CI 1.32, 6.31). The
effect for those with persistent sleep problems was
greater, with almost 4 times the risk in the unadjusted
model (OR 3.73 95% CI 1.92, 7.26) and almost 3.5
times the risk within the adjusted model (OR 3.45 95%
CI 1.59, 7.46). However, those who have resolving sleep
problems are more likely to recover compared to those
with no sleep problems at baseline or follow-up (see
Table 3).
DISCUSSION
This study tested the relationship of sleep problems to
perceived recovery and pain intensity among a cohort of
LBP patients who attended a pain management clinic.
This study tested the prospective relationship and
examined the effect of persistent, developing, and
resolving sleep problems on outcomes. Our findings
support the study hypotheses: the presence of sleep
problems is a significant risk factor for nonrecovery and
pain intensity for those with LBP; and the risk of poor
outcome is elevated in those who develop sleep prob-
lems, with added risk if the person has persistent sleep
problems, and reduced risk for those whose sleep
problems resolve over the course of their back pain.
Comparison to the existing literature shows LBP
prevalence in Iran is comparable to that in European
countries and other countries worldwide, with similar
associated risk factors.1,31,32 While the current cohort
Table 2. Logistic Regression Odds Ratio (OR) with 95% Confidence Intervals (95% CI) for Relationship of Sleep
Problems with Nonrecovery for Those with Low Back Pain
Sleep Problem Status Unadjusted OR (95% CI) Adjusted* OR (95% CI)
No sleep problems Reference category Reference category
Sleep problems 1.52 (1.10, 2.08) 1.50 (1.09, 2.17)
Exploratory baseline and follow-up group analysis
No sleep problems (none at baseline, none at follow-up) Reference category Reference category
Developing sleep problems (none at baseline, present at follow-up) 2.93 (1.53, 5.61) 2.17 (1.04, 4.52)
Persistent sleep problems (present at baseline and follow-up) 3.24 (1.63, 6.43) 2.95 (1.48, 5.88)
Resolving sleep problems (present at baseline, not present at follow-up) 0.49 (0.31, 0.78) 0.50 (0.31, 0.81)
*Baseline adjustment for: pain intensity, depressive and anxiety symptoms, age, gender, occupational status, and duration of back pain.
Table 3. Logistic Regression with 95% Confidence Intervals (95% CI) for Relationship of Sleep Problems with Pain
Intensity for Those with Low Back Pain
Sleep Problem Status Unadjusted OR (95% CI) Adjusted* OR (95% CI)
No sleep problems Reference category Reference category
Sleep problems 2.69 (1.72, 4.11) 2.48 (1.62, 3.70)
Exploratory baseline and follow-up group analysis
No sleep problems (none at baseline, none at follow-up) Reference category Reference category
Developing sleep problems (none at baseline, present at follow-up) 2.99 (1.51, 5.92) 2.88 (1.32, 6.31)
Persistent sleep problems (present at baseline and at follow-up) 3.73 (1.92, 7.26) 3.45 (1.59, 7.46)
Resolving sleep problems (present at baseline, not present at follow-up) 0.46 (0.25, 0.87) 0.49 (0.26, 0.93)
*Baseline adjustment for: pain intensity, depressive and anxiety symptoms, age, gender, occupational status, and duration of back pain.
Sleep Study  83
reported a higher level of pain intensity compared to
community-based LBP or chronic pain samples,23,33 it
reported similar levels to population norms for patients
seeking treatment for LBP or attending pain manage-
ment clinics, as was the case in this study.34,35 The mean
score for the PSQI within the current cohort (10.5) was
generally higher than that for community-dwelling
individuals (mean range 4 to 6),36,37 but this study’s
score is within the expected range for individuals with
pain, comorbidity, sleep problems (eg, insomnia), and
poor health.38,39 In terms of the effect of sleep problems,
2 recent longitudinal studies reported effects similar to
those in this study of the role of the reduction in sleep
problems in reducing reports of pain at follow-up and
the effect sizes reported.40,41
A major strength of this study is the prospective
design, which enabled analysis of the predictive effects
of sleep problems on outcomes in people with LBP. In
addition, the study described effects for those who
presented with sleep problems at baseline, those who
subsequently developed sleep problems after baseline,
and those whose sleep problems resolved at follow-up,
which gives a better perspective on the timing and
sequences of sleep problems and the effects they have on
patient-reported recovery and pain intensity. Another
strength of this study is the consideration of potential
confounds within the analysis. For example, depression
has a known reciprocal relationship with both pain and
sleep, with sleep problems being a diagnostic feature of
depression12,42; therefore, it was important to account
for the potential effects of this within the analysis.
Another important factor accounted for within the
regression analysis was the duration of back pain prior
to the patient entering the study. It was important to
control for the effect of duration of back pain because
research has shown that those with a longer duration of
back pain (ie, chronic) have an increased risk for poor
outcome in general.43 However, this study did not
account for other important confounds such as caffeine
intake, comorbidity, and medication use (analgesia,
sleep medication); any one, or all, of these may have
influenced the effects reported. There are also limita-
tions in terms of the sample. This study recruited a
convenience sample of consecutive patients attending a
chronic pain clinic. Firstly, recruitment was not aligned
to the treatment stage of each patient (ie, not every
patient was at the beginning stage of their treatment),
and so the trajectory or course of pain and sleep will
differ with this case mix. The current study’s results on
the “developing sleep group” give some insight into
these effects; however, incidence cohort studies (ie, onset
of sleep problems in patients with pain) will be better
placed to give greater detail to the patterns and
relationships over time. Secondly, severity of symptoms
(sleep problems, pain, comorbidity) would likely be
higher within the current chronic pain clinic cohort,
compared to general populations or primary care
populations. Therefore, the results in the current study
may represent an overestimation of the association
effects. Nevertheless, both primary care and general
population samples contain subpopulations with high
levels of pain and sleep problems,7,12 where particular
individuals may be at similar or higher risk for poor
outcomes. While the measure of sleep problems used in
this study is validated, and broadly used in epidemio-
logical studies,24,26 it still only captures a subjective
rating of sleep quality. The use of objective measures (eg,
polysomnography, actigraphy) may have improved the
accuracy of our estimates, although this would have
proved difficult to apply in large samples such as this
one. Finally, while there is clinical utility in the use of
“cut points” (eg, in this study the recovery measure, the
pain intensity recovery measure, and the indication of
significant sleep problems) to potentially identify groups
of patients who may benefit from additional treatment, a
limitation is that this study may have missed changes in
individuals within the subgroup categories.
The key message derived from the results is that
sleep problems significantly predict poor outcome for
those with LBP who are seeking treatment. The effect
sizes for those presenting with sleep problems at
baseline indicate significant increased risk for poor
outcome and pain intensity at follow-up, and exami-
nation of groups accounting for the presence of sleep
problems through time show larger effects with
roughly triple the risk for nonrecovery, and presence
of pain intensity, due to the presence of sleep
problems. Moreover, the design of this study allowed
examination of the development of sleep problems,
which showed that almost one-fourth of patients
developed sleep problems that were associated with
poor outcome, while in comparison the proportion of
sleep problems that resolved was relatively small. This
finding highlights not only a need to evaluate and
perhaps address sleep problems in the presenting
patient, but also to be aware of the potential risk to
patients for developing sleep problems, and so moni-
toring and assessment of sleep problems may be
beneficial. A further noticeable finding, albeit in a
small proportion, is that those who reported that their
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sleep problems had resolved were more likely to report
recovery, compared to those who had not reported
sleep problems at all. This may reflect the intrinsic link
between pain and sleep,10 and may suggest that to
address both within treatment may have an additive
positive effect on recovery, over and above targeting
pain or sleep independently. Indeed, early evidence is
now emerging on the benefits of targeting sleep
problems in those with pain. A recent meta-analysis
by Tang et al.44 considered evidence of nonpharmaco-
logical randomized controlled trial interventions tar-
geted at sleep for adults who reported long-term pain.
Results showed significant reductions in sleep prob-
lems, fatigue, and pain at post-treatment.
CONCLUSION
This study of patients with LBP showed increased risk
for poor outcomes in those with LBP who reported sleep
problems. Clinicians may wish to consider treatment
options that involve addressing sleep problems as part of
their treatment.
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